Then, we selected the top 5 relevant immunomodulators, including an immunostimulator (CD276), two immunoinhibitors (IL10RB and TGFBR1), a chemokine (CXCL10) and an MHC (HLA-A), in the glioma dataset and drew scatterplots (Figure 6B) to show their details. Here, TGFBR1 is linked to central nervous system cancer.